Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled time : 13:15 save search
Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin's Potential Inclusion in Government-Sponsored COVID-19 Trials
Published: 2021-11-12 (Crawled : 13:15) - biospace.com/
IPIX | $0.0042 92.86% 1.4K
|
Manufacturing
|
| O: 5.38%
H: 15.96%
C: -5.85%
covid phase 2 potential results trials trial trial results covid-19
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S.
Published: 2021-11-09 (Crawled : 13:15) - inovio.com
INO | $10.36 -0.1% 78K
|
Health Technology
|
| O: 4.79%
H: 7.71%
C: 0.71%
covid fda vaccine phase 3 ino-4800
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
IBRX | $5.27 -4.01% 2.5M
|
Manufacturing
|
| O: -1.84%
H: 2.46%
C: -0.23%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.0%
H: 0.49%
C: -8.46%
covid partnership vaccine covid-19
Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP) Vials, Essential for COVID-19 Care
Published: 2021-11-08 (Crawled : 13:15) - biospace.com/
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: 17.07%
H: 6.49%
C: 2.02%
covid injection
Charlize Theron on COVID-19, youth empowerment, and revolution in Philippine Digicon 2021
Published: 2021-10-29 (Crawled : 13:15) - prnewswire.com
PHI | $23.38 -1.39% 6.3K
|
Communications
|
| O: -0.18%
H: 0.12%
C: -0.55%
covid covid-19
Giant Food Announces COVID-19 Vaccine Booster Shots Available at all Pharmacy Locations
Published: 2021-09-27 (Crawled : 13:15) - prnewswire.com
JNJ | News | $147.27 -1.53% 2.3M
|
Health Technology
|
| O: -0.44%
H: 0.22%
C: -0.51%
covid food vaccine covid-19
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
Published: 2021-09-23 (Crawled : 13:15) - biospace.com/
OSUR | News | $5.45 -1.45% 120K
|
Health Technology
|
| O: 0.54%
H: 2.31%
C: -0.62%
covid test research authorized clearance
Worldwide COVID-19 Diagnostics Industry to 2025 - Players Include Abbott Diagnostics, Applied BioCode and BillionToOne Among Others
Published: 2021-09-21 (Crawled : 13:15) - prnewswire.com
TMO | News | $568.365 -1.08% 680K
|
Health Technology
|
| O: 0.56%
H: 1.56%
C: 0.6%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: 0.28%
H: 0.85%
C: -0.38%
covid diagnostics diagnostic
SD-WAN Sourcing and Procurement Market by 2024 | COVID-19 Impact & Recovery Analysis | SpendEdge
Published: 2021-09-21 (Crawled : 13:15) - prnewswire.com
HPQ | $27.46 -0.76% 1.4M
|
Electronic Technology
|
| O: 0.92%
H: 0.07%
C: -2.4%
covid covid-19
Eiger BioPharmaceuticals Announces Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: -2.36%
H: 1.28%
C: -0.14%
covid biopharma phase 3
Clover Health to Provide In-Home COVID-19 Vaccinations to Medicare Advantage Members
Published: 2021-09-16 (Crawled : 13:15) - globenewswire.com
CLOV | News F | $0.6416 1.86% 590K
|
|
| O: 1.59%
H: 3.86%
C: -1.93%
covid vaccine covid-19
Global $9.9 Billion Remdesivir Markets, 2021-2026 with 2020 as the Base Year - Focus on SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV
Published: 2021-08-12 (Crawled : 13:15) - prnewswire.com
GILD | $66.55 -0.72% 1.6M
|
Health Technology
|
| O: 0.59%
H: 1.07%
C: 0.9%
covid sars-cov-2
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
SRNE | $0.015 56K
|
Health Technology
|
| O: 0.0%
H: 1.36%
C: 0.68%
DYAI 4 | $1.49 1K
|
Health Technology
|
| O: 20.33%
H: 28.7%
C: 22.22%
covid vaccine license technology
Cardinal Health partners with Abbott and Quidel to offer rapid OTC COVID-19 tests
Published: 2021-08-10 (Crawled : 13:15) - biospace.com/
CAH | $103.26 -0.11% 260K
|
Distribution Services
|
| O: -0.49%
H: 1.21%
C: 1.11%
QDEL | News 4 | $39.29 -2.75% 230K
|
Health Technology
|
| O: 0.92%
H: 1.37%
C: -0.69%
covid test health covid-19
Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test
Published: 2021-08-05 (Crawled : 13:15) - prnewswire.com
OCDX | News | $17.63 0.45%
|
|
| O: -1.37%
H: 0.74%
C: -3.9%
covid offering test antibody leo diagnostics merge authorized diagnostic emergency use authorization
ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19
Published: 2021-07-14 (Crawled : 13:15) - biospace.com/
IBRX | $5.27 -4.01% 2.5M
|
Manufacturing
|
| O: 0.77%
H: 1.35%
C: -5.32%
covid phase 1 vaccine trial t-cell authorized africa
Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India
Published: 2021-06-29 (Crawled : 13:15) - biospace.com/
MRNA | News S | $107.16 -0.68% 1.7M
|
Health Technology
|
| O: -0.78%
H: 7.78%
C: 6.0%
covid india vaccine
Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress
Published: 2021-06-25 (Crawled : 13:15) - prnewswire.com
AMPE | $0.286 8K
|
Health Technology
|
| O: 2.81%
H: 1.09%
C: -5.46%
covid respiratory
VivoPower International PLC Announces Contract to Supply Electrical Generators for COVID-19 Vaccine Hub
Published: 2021-06-24 (Crawled : 13:15) - globenewswire.com
VVPR J | $3.55 -1.39% 43K
|
Utilities
|
| O: -2.51%
H: 0.38%
C: -1.41%
covid contract vaccine covid-19
Progress Arms Marketers for Post-COVID Reality with Latest Release of Sitefinity Insight
Published: 2021-06-22 (Crawled : 13:15) - globenewswire.com
PRGS | $51.4 -0.06% 61K
|
Technology Services
|
| O: -0.42%
H: 0.67%
C: 0.09%
covid test
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.